Vaxcyte, Inc. PCVX
$49.72
▲ +0.36% 24H
About
Vaxcyte Inc. is a biotechnology company focused on developing innovative vaccines for preventing infectious diseases. The primary objective of the company is to create safer and more effective vaccines using its proprietary cell-free protein synthesis platform, a groundbreaking technology that aims to enhance vaccine d…
SectorHealthcare
ExchangeNASDAQ
IndustryBiotechnology
CountryUnited States
Employees507
TickerPCVX
Statistics
Market Cap$7.18B
Revenue (TTM)$0
Net Income-$766.6M
Net Margin—
EPS$-5.63
P/E-8.43
P/S—
P/B2.19
EV/EBITDA-4.61
ROE-30.6%
Dividend Yield—
Price$49.72
Data: Twelve Data · Revenue = mcap / P/S